AIDX
What one share of 20/20 Biolabs holds
Services – Testing Laboratories
20/20 Biolabs’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.29 |
|---|---|
| Profit | −$0.82 |
| Cash and investments | $0.37 |
| Debt | $0.06 |
| Book value | $0.13 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.36 | −$1.16 | — | — | — | $0.31 |
| 2025 | $0.41 | −$0.76 | — | — | — | −$0.00 |
Common questions about 20/20 Biolabs
How much does one share of 20/20 Biolabs earn?
Over the last 12 months, 20/20 Biolabs lost $0.82 for each share on $0.29 of sales.
Does 20/20 Biolabs pay a dividend?
20/20 Biolabs didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is 20/20 Biolabs’s book value per share?
20/20 Biolabs’s book value is $0.13 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of 20/20 Biolabs have?
Each share of 20/20 Biolabs has $0.37 of cash and investments and $0.06 of debt, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.